Table 4 Differentially expressed metabolites in human enviromimetic organoids.
Enviromimetic drug/Risk factor treatment group | ||||||
|---|---|---|---|---|---|---|
WIN | IL17a | CORT | Nicotine | Ethanol | Endomorphin | |
3-Phosphoglyceric Acid | ↓ | ↓ | ||||
Acetylcysteine | ↓ | |||||
Allantoin | ↓ | ↓ | ||||
Creatinine | ↓ | ↓ | ↓ | ↓ | ||
D-Ribose 5-Phosphate | ↓ | |||||
Guanosine Monophosphate | ↓ | |||||
Guanosine Triphosphate | ↑ | ↑ | ↑ | ↑ | ↑ | |
Inosine | ↓ | |||||
L-Leucine | ↓ | ↓ | ↓ | |||
L-Methionine | ↓ | ↓ | ↓ | ↓ | ↓ | |
L-Phenylalanine | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ |
L-Tyrosine | ↓ | ↓ | ↓ | ↓ | ↓ | |
L-Valine | ↓ | ↓ | ↓ | ↓ | ||
N-Acetylglutamine | ↓ | |||||
N-Acetylornithine | ↓ | ↓ | ↓ | |||
Pyruvic Acid | ↓ | |||||
S-Adenosylhomocysteine | ↓ | ↓ | ||||
Succinic Acid | ↓ | |||||